Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

novo_nordisk_flag

Novo Nordisk cuts 650 roles around the world in R&D restructure

October 1, 2018 Manufacturing and Production, Sales and Marketing China, Denmark, Novo Nordisk, UK, US, pharma

Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …
News
800px-t_lymphocyte_16760076824

Antibody therapy supresses HIV for months after treatment, study shows

October 1, 2018 Sales and Marketing HIV, immunology, immunotherapy, nature, research

Researchers from the New York City based Rockefeller University have developed a novel immunotherapy, which is capable of suppressing HIV …
News

Roche acquires immuno-oncology biotech Tusk in €655m deal

October 1, 2018 Sales and Marketing Droia, Roche, Tusk, immuno-oncology, immunology, oncology

Swiss multinational Roche has acquired the privately held immuno-oncology company Tusk Therapeutics in a deal that could be worth up …
News
mcewan

Ipsen appoints two leading R&D experts in bid to strengthen oncology arm

September 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, R&D, development, ipsen, oncology, research

French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …
News
gilead-sciences

Gilead to release generic versions of hep C meds over a decade before patent expiry

September 28, 2018 Medical Communications, Sales and Marketing Epclusa, Gilead, generics, harvoni, hepatitis C, pharma

Gilead has announced its intention to undercut itself by releasing generic versions of its blockbuster drugs for the treatment of …
News
shutterstock_273326141

Novartis joins forces with GARDP for better, accessible infectious disease treatments in the developing world

September 27, 2018 Research and Development, Sales and Marketing GARDP, Novartis, infectious disease, pharma

Novartis has partnered up with the Global Antibiotic Research & Development Partnership (GARDP) to push for faster development and wider …
News
life_sciences_scotland_edit

Life Sciences Scotland appoints two MSPs to their Industry Leadership Group

September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Scotland, Scotland, economic development, pharma

Life Sciences Scotland, an organisation focused towards developing the life sciences industry in the northernmost constituent country of the United …
Appointment
kenneth_c

Kenneth Frazier to continue as CEO as MSD rescinds mandatory retirement policy

September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kenneth Frazier, MSD, pharma

MSD has pitched a curveball with the news that the company has rescinded its policy mandating that Chief Executive Officers …
News
pharmafocus_october_2018

The October 2018 issue of Pharmafocus is available to read online now!

September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma

The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …
News

Roche’s entrectinib shrinks lung tumours with two-year response duration

September 25, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, NSCLC, NSCLC< lung cancer, Roche, entrectinib

Roche was unveiled new Phase 1 and 2 data for entrectinib in the treatment of locally advanced or metastatic ROS1-positive …
News
astrazeneca_building_white

AstraZeneca chalks up European approval for Imfinzi in locally advanced, unresectable lung cancer

September 25, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MedImmune, NSCLC, lung cancer, pharma

AstraZeneca and its global biologics R&D arm MedImmune have announced the approval by the European Commission of Imfinzi (durvalumab) as …
News

Working Life: Jean-Christophe Tellier, CEO of UCB Pharma

September 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, Working Life, feature

Just as his company announced robust H1 2018 financials, UCB’s Jean-Christophe Tellier spoke to Pharmafocus to share his experiences of …
Feature
6813384933_1fb31d73fb_z

HIV on the rise among straight men in Australia

September 24, 2018 Medical Communications, Sales and Marketing AIDS, Aboriginal, Australia, HIV, Kirby Institute

The number of new HIV diagnoses is on the rise among heterosexual men in Australia, according to a new report …
News
7359dba7-e1da-4eb4-8765-58da6178899b

Sarepta’s Exondys 51 hit with negative CHMP opinion in Duchenne muscular dystrophy

September 24, 2018 Research and Development, Sales and Marketing CHMP, Duchenne Muscular Dystophy, EMA, Europe, Exondys 51, pharma, sarepta

Sarepta Therapeutics has been rocked by a hurdle in its pursuit of regulatory approval in Europe, as the company revealed …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025